Skip to content
Bored Studies
RecruitingPhase 1

Achilles Tendinopathy Embolization

Joint & Vascular Institute · NCT07477860

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 25–80 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 1
Target enrollment
10
US sites recruiting
1
Study start
April 1, 2026
Record last updated
April 23, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this clinical trial is to learn determine the feasibility of arterial embolization using Lipiodol emulsion to safely and effectively treat chronic Achilles tendon pain due to Achilles tendinopathy in adults aged 25 to 80. The main questions it aims to answer are:

  • Does this procedure successfully reduce chronic Achilles tendon pain as measured by the Visual Analog Scale (VAS) over 12 months?
  • How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device?

Participants will

  • Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels supplying the Achilles tendon.
  • Receive a phone call one day after the procedure to check for early side effects.
  • Participate in four follow-up visits over the course of one year (at 1, 3, 6, and 12 months).

Complete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.

Being studied: LipioJoint

Conditions: Achilles Tendinopathy (AT)

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Age ≥ 25 years
  • Subject provides written informed consent
  • Patient with Achilles tendinopathy refractory to 3 months of conservative management
  • Self reported pain of at least 4/10 on visual analog scale (VAS)
  • Non-surgical candidate/looking to avoid surgery

Exclusion Criteria

  • Achilles tendon pain caused by acute fracture, recent trauma, inflammatory conditions, muscle/ligament injury, tendon rupture, and etiologies related to bone mineral density
  • Steroid injection in the last 90 days from the embolization procedure
  • Known severe allergy to Lipiodol and/or iodinated contrast media
  • Diagnosis of peripheral arterial disease affecting the lower extremities
  • Pregnancy or breastfeeding
  • Anticoagulation or irreversible coagulopathy
  • GFR \<45 or Serum creatinine > 2.0 mg/dl
  • Type 1 Diabetes Mellitus

Recruiting US locations

  • Joint and Vascular Institute

    Libertyville, IL 60048

    Site contact: Layth Alkhani · 847-584-3959 · lalkhani@jointvascular.com

Study contacts (from the official record)

  • Layth Alkhani · 847-584-3959 · lalkhani@jointvascular.com
All phase 1 studies in Illinois →
Achilles Tendinopathy Embolization (NCT07477860) | Bored Studies